Voltar
Artigo Revisado por pares
BIBTEX RIS

First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial

2018; Springer Science+Business Media; Volume: 169; Issue: 3 Linguagem: Inglês

10.1007/s10549-017-4658-x

ISSN

1573-7217

Autores

Wolfgang Janni, Emilio Alba, Thomas Bachelot, Sami Diab, Miguel Gil‐Gil, Thaddeus Beck, Larisa Ryvo, Rafael López‐López, Michaela L. Tsai, Francisco J. Esteva, Pilar Auñón, Zdeněk Král, Patrick J. Ward, Paul Richards, Timothy Pluard, Santosh Sutradhar, Michelle C. Miller, Mario Campone,

Tópico(s)

Cancer-related Molecular Pathways

Referência(s)